CMPS•benzinga•
Compass Pathways Pushed Topline Data Readout From COMP005 Phase 3 Trial For COMP360 In Treatment-Resistant Depression To Q2 2025, And COMP006 Data Will Now Be Announced After 26-week Time Point, Expected In 2H Of 2026, Cuts Workforce By 30%
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on October 31, 2024 by benzinga